Valeritas Holdings, Inc. (NASDAQ:VLRX) Announces Quarterly Earnings Results, Beats Expectations By $0.04 EPS
Valeritas Holdings, Inc. (NASDAQ:VLRX) posted its quarterly earnings data on Friday. The company reported ($1.83) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.87) by $0.04, MarketWatch Earnings reports. The firm had revenue of $4.79 million during the quarter, compared to analyst estimates of $5.11 million.
Valeritas Holdings (NASDAQ VLRX) traded down 11.17% on Friday, reaching $5.01. 22,455 shares of the company’s stock were exchanged. Valeritas Holdings has a 12-month low of $4.51 and a 12-month high of $50.00. The company’s market cap is $34.28 million. The firm has a 50 day moving average of $5.92 and a 200-day moving average of $12.45.
In other Valeritas Holdings news, insider John Edward Timberlake purchased 5,000 shares of the stock in a transaction dated Wednesday, May 17th. The shares were acquired at an average cost of $5.14 per share, for a total transaction of $25,700.00. Following the completion of the transaction, the insider now directly owns 23,037 shares of the company’s stock, valued at $118,410.18. The purchase was disclosed in a filing with the SEC, which is available at this link. Insiders bought 11,500 shares of company stock worth $57,615 over the last quarter. Company insiders own 1.20% of the company’s stock.
An institutional investor recently bought a new position in Valeritas Holdings stock. C WorldWide Group Holding A S purchased a new stake in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 233,952 shares of the company’s stock, valued at approximately $1,603,000. C WorldWide Group Holding A S owned about 3.42% of Valeritas Holdings at the end of the most recent quarter. Hedge funds and other institutional investors own 11.65% of the company’s stock.
Several equities research analysts recently issued reports on VLRX shares. ValuEngine cut Valeritas Holdings from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 19th. Wedbush assumed coverage on Valeritas Holdings in a report on Monday, July 10th. They issued an “outperform” rating and a $12.00 price objective on the stock. B. Riley reissued a “buy” rating and issued a $10.00 target price on shares of Valeritas Holdings in a research note on Wednesday, May 17th. Finally, Cowen and Company assumed coverage on shares of Valeritas Holdings in a research note on Monday, April 17th. They issued an “outperform” rating on the stock.
Valeritas Holdings Company Profile
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.